Works matching IS 19466234 AND DT 2017 AND VI 9 AND IP 402

Results: 5

Preventing chemotherapy-induced myelosuppression by repurposing the FLT3 inhibitor quizartinib.
Published in:
Science Translational Medicine, 2017, v. 9, n. 402, p. 1, doi. 10.1126/scitranslmed.aam8060
By:
- Taylor, Samuel J.;
- Duyvestyn, Johanna M.;
- Dagger, Samantha A.;
- Dishington, Emma J.;
- Rinaldi, Catherine A.;
- Dovey, Oliver M.;
- Vassiliou, George S.;
- Grove, Carolyn S.;
- Langdon, Wallace Y.
Publication type:
Article
Genomic profiling of ER+ breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance.
Published in:
Science Translational Medicine, 2017, v. 9, n. 402, p. 1, doi. 10.1126/scitranslmed.aai7993
By:
- Giltnane, Jennifer M.;
- Hutchinson, Katherine E.;
- Stricker, Thomas P.;
- Formisano, Luigi;
- Young, Christian D.;
- Estrada, Monica V.;
- Nixon, Mellissa J.;
- Liping Du;
- Sanchez, Violeta;
- Gonzalez Ericsson, Paula;
- Kuba, Maria G.;
- Sanders, Melinda E.;
- Mu, Xinmeng J.;
- Van Allen, Eliezer M.;
- Wagle, Nikhil;
- Mayer, Ingrid A.;
- Abramson, Vandana;
- Gόmez, Henry;
- Rizzo, Monica;
- Weiyi Toy
Publication type:
Article
Combating corruption in global health.
Published in:
Science Translational Medicine, 2017, v. 9, n. 402, p. 1, doi. 10.1126/scitranslmed.aaf9547
By:
- Mackey, Tim K.;
- Kohler, Jillian;
- Lewis, Maureen;
- Vian, Taryn
Publication type:
Article
Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes.
Published in:
Science Translational Medicine, 2017, v. 9, n. 402, p. 1, doi. 10.1126/scitranslmed.aaf7779
By:
- Alhadj Ali, Mohammad;
- Yuk-Fun Liu;
- Arif, Sefina;
- Tatovic, Danijela;
- Shariff, Hina;
- Gibson, Vivienne B.;
- Yusuf, Norkhairin;
- Baptista, Roman;
- Eichmann, Martin;
- Petrov, Nedyalko;
- Heck, Susanne;
- Yang, Jennie H. M.;
- Tree, Timothy I. M.;
- Pujol-Autonell, Irma;
- Yeo, Lorraine;
- Baumard, Lucas R.;
- Stenson, Rachel;
- Howell, Alex;
- Clark, Alison;
- Boult, Zoe
Publication type:
Article
Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection.
Published in:
Science Translational Medicine, 2017, v. 9, n. 402, p. 1, doi. 10.1126/scitranslmed.aaf1483
By:
- Parsons, Matthew S.;
- Lloyd, Sarah B.;
- Wen Shi Lee;
- Kristensen, Anne B.;
- Amarasena, Thakshila;
- Center, Rob J.;
- Keele, Brandon F.;
- Lifson, Jeffrey D.;
- LaBranche, Celia C.;
- Montefiori, David;
- Wines, Bruce D.;
- Hogarth, P. Mark;
- Swiderek, Kristine M.;
- Venturi, Vanessa;
- Davenport, Miles P.;
- Kent, Stephen J.
Publication type:
Article

Works matching IS 19466234 AND DT 2017 AND VI 9 AND IP 402

Preventing chemotherapy-induced myelosuppression by repurposing the FLT3 inhibitor quizartinib.

Genomic profiling of ER+ breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance.

Combating corruption in global health.

Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes.

Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection.